Article: Gel could treat viral eye infection

Marketing deal

Tampa-Sirion Therapeutics Inc. has made an exclusive licensing agreement with Laboratoires Thea of France for U.S. rights to develop and market a topical ophthalmic gel containing ganciclovir for treating certain viral and superficial eye infections

Thea markets the gel in Europe as Virgan.

If it is approved, the topical ophthalmic antiviral gel would treat herpes simplex keratitis, the leading cause of ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!